In future studies, we can investigate whether 5-HT under EA treatment can exert neuroprotective effects and improve specific signaling pathways associated with neurological injury via 5-HT or further investigate depression-inducing behaviors and solutions induced by increased 5-HT2A expression after cerebral ischemia. This evidence concerns the gene HTR2A and depressive symptom measurement.